Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Triantafyllos Doskas

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2020
Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathwaysIoannis Morianos, Aikaterini I Trochoutsou, Gina Papadopoulou, et al.
Plos One|November 25, 2014
Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA)Georgios Hadjigeorgiou, Efthimios Dardiotis, Georgios Tsivgoulis, et al.
Multiple Sclerosis and Related Disorders|September 30, 2025
Clinical insights and risk factors for disability in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder patients: a multicenter real-world study in GreeceAlexandra Akrivaki, Dimitrios Tzanetakos, Viktor Gkotzamanis, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2020
Activin-A limits Th17 pathogenicity and autoimmune neuroinflammation via CD39 and CD73 ectonucleotidases and Hif1-α-dependent pathwaysIoannis Morianos, Aikaterini I Trochoutsou, Gina Papadopoulou, et al.
Plos One|November 25, 2014
Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA)Georgios Hadjigeorgiou, Efthimios Dardiotis, Georgios Tsivgoulis, et al.
Multiple Sclerosis and Related Disorders|September 30, 2025
Clinical insights and risk factors for disability in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder patients: a multicenter real-world study in GreeceAlexandra Akrivaki, Dimitrios Tzanetakos, Viktor Gkotzamanis, et al.
Pageof 3